Rationale and Design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) RCT# NCT02344290

BACKGROUND: Cardiovascular disease (CVD) is more frequent among people with HIV (PWH) and may relate to traditional and nontraditional factors, including inflammation and immune activation. A critical need exists to develop effective strategies to prevent CVD in this population. METHODS: The Randomi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am Heart J
Main Authors: Grinspoon, Steven K., Fitch, Kathleen V., Overton, Edgar Turner, Fichtenbaum, Carl J., Zanni, Markella V., Aberg, Judith A., Malvestutto, Carlos, Lu, Michael T., Currier, Judith S., Sponseller, Craig A., Waclawiw, Myron, Alston-Smith, Beverly, Cooper-Arnold, Katharine, Klingman, Karin L., Desvigne-Nickens, Patrice, Hoffmann, Udo, Ribaudo, Heather J., Douglas, Pamela S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6535121/
https://ncbi.nlm.nih.gov/pubmed/30928825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2018.12.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados